United States · Platforms & data · Seeking Alpha

Repligen signals at least 25% 2027 top line growth with BioLife, targeting over $1B revenue

Published by Seeking Alpha · United States 1 h ago

Read the full article on Seeking Alpha Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (seekingalpha.com)

Also worth reading

Greenbrier Companies, Inc. (The) (NYSE:GBX) Stock Has Average Price Target of $42.67

Is that used EV worth the price? This checklist could save you thousands of dollars.

Robinhood CEO’s AI startup Harmonic expands into software, chip design verification

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Galaxy Digital Stock Surges After Quarterly Earnings Crush Estimates

Market News